CA1272733C - Compositions for treating glaucoma - Google Patents

Compositions for treating glaucoma

Info

Publication number
CA1272733C
CA1272733C CA 405106 CA405106A CA1272733C CA 1272733 C CA1272733 C CA 1272733C CA 405106 CA405106 CA 405106 CA 405106 A CA405106 A CA 405106A CA 1272733 C CA1272733 C CA 1272733C
Authority
CA
Canada
Prior art keywords
carbon atoms
hydroxy
benzoyl
phenyl substituted
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA 405106
Other languages
English (en)
French (fr)
Other versions
CA1220716A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CA000521655A priority Critical patent/CA1272733A/en
Application granted granted Critical
Publication of CA1220716A publication Critical patent/CA1220716A/en
Publication of CA1272733C publication Critical patent/CA1272733C/xx
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/14Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA 405106 1981-06-23 1982-06-14 Compositions for treating glaucoma Expired - Lifetime CA1272733C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000521655A CA1272733A (en) 1981-06-23 1986-10-28 Compositions for treating glaucoma

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US276,657 1981-06-23
US06/276,657 US4402974A (en) 1981-06-23 1981-06-23 Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA000521655A Division CA1272733A (en) 1981-06-23 1986-10-28 Compositions for treating glaucoma

Publications (2)

Publication Number Publication Date
CA1220716A CA1220716A (en) 1987-04-21
CA1272733C true CA1272733C (en) 1990-08-14

Family

ID=23057572

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 405106 Expired - Lifetime CA1272733C (en) 1981-06-23 1982-06-14 Compositions for treating glaucoma

Country Status (18)

Country Link
US (1) US4402974A (xx)
EP (1) EP0081580B1 (xx)
JP (1) JPS58500997A (xx)
AT (1) AT384017B (xx)
AU (1) AU559541B2 (xx)
CA (1) CA1272733C (xx)
CH (1) CH655497B (xx)
ES (1) ES8401927A1 (xx)
GB (2) GB2112785B (xx)
GR (1) GR76848B (xx)
IL (1) IL66069A0 (xx)
IT (1) IT1156057B (xx)
NL (1) NL8220251A (xx)
NZ (1) NZ200971A (xx)
PH (1) PH18383A (xx)
SE (1) SE464300B (xx)
WO (1) WO1983000043A1 (xx)
ZA (1) ZA824339B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
US4604481A (en) * 1980-11-28 1986-08-05 American Hospital Supply Corporation Compounds for treatment or prophylaxis of cardiac disorders
EP0053893B1 (en) * 1980-12-09 1985-03-20 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
US4579867A (en) * 1984-04-09 1986-04-01 American Hospital Supply Corporation Stable pharmaceutical compositions of short-acting β-adrenergic receptor blocking agents
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US4966914A (en) * 1988-12-15 1990-10-30 E. I. Du Pont De Nemours And Company Oculoselective beta-blockers as antiglaucoma agents
US4897417A (en) * 1988-12-15 1990-01-30 E. I. Du Pont De Nemours & Co. Prodrugs of 3,4-hydroxy benzoyloxypropanolamines
CH679856A5 (xx) * 1990-07-04 1992-04-30 Lonza Ag
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5543083A (en) * 1994-07-26 1996-08-06 The Procter & Gamble Company Fatty amine derivatives of butylated hydroxy toluene for the protection of surfaces from physical and chemical degradation
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
US6197817B1 (en) 1999-01-22 2001-03-06 Selectus Pharmaceuticals, Inc. Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders
US7209743B2 (en) * 2004-04-22 2007-04-24 Telefonaktiebolaget Lm Ericsson (Publ) Base station system and method for compensating traffic channel signal strength measurements in a cellular radio telecommunication network
AU2005247480A1 (en) * 2004-05-25 2005-12-08 Qlt Inc. Oculoselective drugs and prodrugs
US20080300292A1 (en) * 2004-11-08 2008-12-04 Nitromed, Inc Nitrosated and Nitrosylated Compounds, Compositions and Methods for the Treatment of Ophthalmic Disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL75127C (xx) * 1943-10-05
FR1047364A (fr) * 1950-12-28 1953-12-14 Hoechst Ag Esters d'acides alcoylamino-benzoïques, sels d'acides minéraux de ces esters et procédé de préparation de ces corps
NL300886A (xx) * 1962-11-23
US3959351A (en) * 1972-07-24 1976-05-25 Research Corporation Haloalkylbenzoyl esters of di-lower alkylamino alkanols and quaternary lower alkyl salts thereof
US4195085A (en) * 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
DE2752659A1 (de) 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
DE2962112D1 (en) * 1978-02-08 1982-03-25 Ici Plc Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
ZA824339B (en) 1983-04-27
IT8267795A0 (it) 1982-06-22
EP0081580B1 (en) 1987-04-22
GR76848B (xx) 1984-09-04
NL8220251A (nl) 1983-05-02
EP0081580A4 (en) 1983-12-01
AU8737582A (en) 1983-01-18
SE8300912L (sv) 1983-02-18
JPS58500997A (ja) 1983-06-23
GB2112785B (en) 1985-06-05
GB8303060D0 (en) 1983-03-09
GB2145721A (en) 1985-04-03
ES513386A0 (es) 1984-01-01
IL66069A0 (en) 1982-09-30
ES8401927A1 (es) 1984-01-01
GB2112785A (en) 1983-07-27
JPH0428696B2 (xx) 1992-05-15
GB8421939D0 (en) 1984-10-03
ATA903482A (de) 1987-02-15
SE464300B (sv) 1991-04-08
NZ200971A (en) 1985-12-13
IT1156057B (it) 1987-01-28
AT384017B (de) 1987-09-25
CH655497B (xx) 1986-04-30
PH18383A (en) 1985-06-19
AU559541B2 (en) 1987-03-12
GB2145721B (en) 1986-02-19
SE8300912D0 (sv) 1983-02-18
WO1983000043A1 (en) 1983-01-06
CA1220716A (en) 1987-04-21
US4402974A (en) 1983-09-06
EP0081580A1 (en) 1983-06-22

Similar Documents

Publication Publication Date Title
CA1272733C (en) Compositions for treating glaucoma
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
ES8401067A1 (es) Procedimiento analogo para preparar un derivado de tropil benzoato.
ES449096A1 (es) Un procedimiento para la preparacion de 11-desoxi-16-ariloxi-omega-tetranorprostaglandinas.
ES8507467A1 (es) Procedimiento de obtencion de agentes beta-bloqueantes conteniendo grupos ester con propiedades oftalmologicas
DE3361369D1 (en) Indanyl derivatives, their preparation and their use
ES471594A1 (es) Procedimiento para la preparacion de alfa-halometil deriva- dos de amino acido
ES475120A1 (es) Un procedimiento para la preparacion de imidazo (1,5-b)piri-dazinas.
ZA864361B (en) Benzaldoxime carbamate derivatives
DE3161263D1 (en) Thiazole derivatives, their preparation and use in therapeutics
ES8304956A1 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
ES473775A1 (es) Perfeccionamientos en o relacionados con compuestos organi- cos
ZA80742B (en) Thiazole derivatives and their use in therapy
DE3271277D1 (en) Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment
MY104099A (en) Anti inflammatory carbinoloimidazoles.
JPS53124618A (en) Herbicidal and plant growth regulating agent

Legal Events

Date Code Title Description
MKEX Expiry
MKEX Expiry

Effective date: 20040421